Immunomodulation of cancer with activated cytotoxic leukocytes.
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20814.
H C
HC
Stevenson
G W
GW
Stevenson
D003602:Cytotoxicity, Immunologic; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D007962:Leukocytes / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D007155:Immunologic Factors